Delayed pressure urticaria: Clinical features, laboratory investigations, and response to therapy of 44 patients

https://doi.org/10.1016/S0190-9622(88)70137-1Get rights and content

Abstract

We studied 44 patients with delayed pressure urticaria. The mean age at onset of the disease was 33 years (range, 5 to 63 years) and the mean duration of disease was 9 years (range, 1 to 40 years). After pressure stimulus, the mean onset of whealing occurred in 3 1/2 hours, the mean peak swelling occurred after 10 hours, and the mean lesion duration was 36 hours. Two thirds of patients had generalized flulike symptoms. Sixty percent had disabling nonremitting delayed pressure urticaria. Sixty-two percent had coexistent chronic idiopathic urticaria, and 27% had angioedema. Delayed pressure urticaria was confirmed by pressure tests with either a calibrated dermographometer or suspended weights. More than 50% of patients tested also had delayed dermographism. A double-blind, controlled, crossover trial of indomethacin therapy in 14 patients revealed no Significant subjective improvement or reduction in area of induced wheals. We conclude: (1) The diagnosis of delayed pressure urticaria can be easily made by dermographometer testing. (2) Delayed dermographism may be the same entity as delayed pressure urticaria induced by a different method of pressure application. (3) Systemic corticosteroids remain the only known effective treatment for disabling delayed pressure urticaria.

References (30)

  • RH Champion et al.

    Urticaria and angioedema: a review of 554 patients

    Br J Dermatol

    (1969)
  • TJ Ryan et al.

    Delayed pressure urticaria

    Br J Dermatol

    (1968)
  • HMG Doeglas et al.

    Protease inhibitors in plasma of patients with chronic urticaria

    Arch Dermatol

    (1975)
  • L Illig

    Physical urticaria: Its diagnosis and treatment

  • RD Carr et al.

    Incidence of atopy in the general population

    Arch Dermatol

    (1964)
  • Cited by (86)

    • Delayed Pressure Urticaria: A Systematic Review of Treatment Options

      2020, Journal of Allergy and Clinical Immunology: In Practice
      Citation Excerpt :

      Skin provocation testing was performed to assess treatment response in all the 8 RCTs6,9,25,28-32 and in 2 of the 13 non-RCTs.22,34 Three RCTs6,9,31 used dermographometer testing, 3 RCTs25,29,30 used 7-kg weight pressure testing, and 2 RCTs28,32 used steel rods (weighing 3.5 kg; diameter 15 mm). One non-RCT34 used 15-lb weight pressure testing, and another non-RCT21 used weighted metal rods.

    • The diagnosis and management of acute and chronic urticaria: 2014 update

      2014, Journal of Allergy and Clinical Immunology
    • Contemporary approaches to the diagnosis and management of physical urticaria

      2013, Annals of Allergy, Asthma and Immunology
      Citation Excerpt :

      Short courses of oral corticosteroids may be required, but long-term use of oral corticosteroids is not recommended. Some cases of DPUA may benefit from nonsteroidal anti-inflammatory drugs, but no statistically significant benefit was found in a double-blinded trial with indomethacin 25 mg 3 times a day compared with placebo.30,32 Because many patients with physical urticaria also have spontaneous CU outbreaks, which may be exacerbated by the administration of cyclooxygenase-1–inhibiting drugs, prescribing aspirin or aspirin-like drugs to patients with DPUA should be approached cautiously.82

    View all citing articles on Scopus

    Presented in part at the meeting of the British Association of Dermatologists, Sheffield, England, July 11, 1986.

    *

    From St. John's Hospital for Diseases of the Skin and The Dermatology Institute, London

    **

    Protein Reference Laboratory, Hallamshire Hospital Medical School, Sheffield.

    View full text